VICEOLIS Trademark

Trademark Overview


On Wednesday, November 3, 2021, a trademark application was filed for VICEOLIS with the United States Patent and Trademark Office. The USPTO has given the VICEOLIS trademark a serial number of 79327762. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 24, 2023. This trademark is owned by Vicore Pharma AB. The VICEOLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis, namely, ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for infectious lung diseases; pharmaceutical preparations for covid-19
viceolis

General Information


Serial Number79327762
Word MarkVICEOLIS
Filing DateWednesday, November 3, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis, namely, ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for infectious lung diseases; pharmaceutical preparations for covid-19

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVicore Pharma AB
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressSE

Trademark Events


Event DateEvent Description
Wednesday, February 14, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 24, 2024FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 24, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, October 22, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 24, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, January 24, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 26, 2022REFUSAL PROCESSED BY IB
Friday, July 1, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 1, 2022REFUSAL PROCESSED BY MPU
Wednesday, June 29, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 28, 2022NON-FINAL ACTION WRITTEN
Wednesday, June 22, 2022ASSIGNED TO EXAMINER
Friday, January 21, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 14, 2021APPLICATION FILING RECEIPT MAILED
Friday, December 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB